RDNT Overview

RadNet, Inc. is a national provider of fixed-site diagnostic imaging services in the United States. The Company has a network of 407 owned and/or operated outpatient imaging centers. Its Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Its services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. Its Digital Health segment develops and deploys clinical applications to enhance interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics. It provides radiology information technology and artificial intelligence (AI) solutions marketed under the DeepHealth brand and teleradiology professional services. It is also a provider of AI-powered breast health solutions.

Wall Street analysts forecast RDNT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for RDNT is90.17 USD with a low forecast of 86.00 USD and a high forecast of 95.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

RadNet Inc revenue for the last quarter amounts to 547.71M USD, increased 14.80

RadNet Inc. EPS for the last quarter amounts to -0.01 USD, decreased -114.29

RadNet Inc (RDNT) has 8844 emplpoyees as of March 12 2026.

Today RDNT has the market capitalization of 4.75B USD.